-
EVOLVING CODING PRACTICES FOR PRIMARY IGA NEPHROPATHY IN GERMAN CLAIMS DATA: EVIDENCE FROM 2022-2024
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT OF SUBCUTANEOUS IMMUNOGLOBULIN 20% (IGPRO20) IN CIDP FROM A GERMAN STATUTORY HEALTH INSURANCE PERSPECTIVE
Aug 11, 2026, 17:15 PM -
EVALUATION OF COST-EFFECTIVENESS MODELS FOR LIPID-LOWERING THERAPIES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PREVENTION: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
CONSANGUINITY-ADJUSTED BUDGET IMPACT OF ORPHAN DRUG ACCESS FOR HEREDITARY TYROSINEMIA TYPE 1 IN MOROCCO: A PAYER-PERSPECTIVE MODEL
Aug 11, 2026, 17:15 PM -
EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES OF ONCE-WEEKLY SOMAPACITAN AND SOMATROGON IN CHILDREN WITH GROWTH HORMONE DEFICIENCY: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:15 PM -
ESTIMATING THE UK POPULATION ELIGIBLE FOR LATE-LINE MULTIPLE MYELOMA THERAPIES USING AN EPIDEMIOLOGICAL MODEL
Aug 11, 2026, 17:15 PM -
CHARACTERIZING FGFR BIOMARKER TESTING IN METASTATIC UROTHELIAL CARCINOMA THROUGH NORSTELLALINQ LINKED CLAIMS AND ELECTRONIC HEALTH RECORDS, INCLUDING CLINICAL NOTES WITH HUMAN-IN-THE-LOOP LLM EXTRACTION
Aug 11, 2026, 17:15 PM -
CAPTURING THE DOWNSIDE: A TARGETED REVIEW OF ADVERSE EVENT COSTS AND DISUTILITY VALUES IN NICE APPRAISALS
Aug 11, 2026, 17:15 PM -
PRICE NEGOTIATION FOR HIGH-COST THERAPIES: A REVIEW OF THEORIES, STRATEGIES AND FACTORS INFLUENCING BARGAINING POWER
Aug 11, 2026, 17:15 PM -
TIME TO REIMBURSEMENT OF MULTIPLE SCLEROSIS THERAPIES IN POLAND ANALYSIS OF HTA SUBMISSION AND REIMBURSEMENT DECISIONS
Aug 11, 2026, 17:15 PM -
DEVELOPMENT OF A NEW COST-EFFECTIVENESS MODEL FOR CHRONIC HEPATITIS B VIRUS INFECTION BASED ON THE B-WELL TRIAL: VALIDATION OF HYBRID COHORT MODEL APPROACH
Aug 11, 2026, 17:15 PM -
THE ECONOMIC AND HUMANISTIC BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN UAE
Aug 11, 2026, 17:15 PM -
FEASIBILITY OF IDENTIFYING GENOTYPE-DEFINED DUCHENNE MUSCULAR DYSTROPHY POPULATIONS USING HUMAN-IN-THE-LOOP LLM AND LINKED CLINICAL NOTES FROM NORSTELLALINQ EHR
Aug 11, 2026, 17:15 PM -
TELEMEDICINE COST SAVINGS ARE CONDITIONAL RATHER THAN AUTOMATIC: A SYSTEMATIC REVIEW OF ECONOMIC EVIDENCE AND ITS IMPLICATIONS FOR REMOTE AND UNDERSERVED HEALTH SYSTEMS
Aug 11, 2026, 17:15 PM -
FROM STANDALONE AI TO NATIONAL WORKFLOW: INDEPENDENT EVALUATION OF AN ELECTIVE-CARE RISK-STRATIFICATION TOOL'S CLINICAL AND BUDGET IMPACT, WITH FEDERATED DATA PLATFORM INTEGRATION
Aug 11, 2026, 17:15 PM -
INTRODUCING IN THE NATIONAL IMMUNIZATION PROGRAM THE 20-VALENT PNEUMOCOCCAL VACCINE IN OLDER ADULTS IN ECUADOR: A COST-UTILITY ANALYSIS
Aug 11, 2026, 17:15 PM -
MODELING MULTI-DOSE MALARIA VACCINE IMPLEMENTATION IN NIGERIA: INSIGHTS FROM NATIONAL VACCINE DOSE PROGRESSION PATTERNS
Aug 11, 2026, 17:15 PM -
A METHODOLOGICAL FRAMEWORK FOR REAL-WORLD EVIDENCE GENERATION IN ITALIAN COMMUNITY PHARMACIES: APPLICATION IN THE FLORA STUDY
Aug 11, 2026, 17:15 PM -
HOSPITAL RESOURCE OPTIMIZATION WITH SUBCUTANEOUS IMMUNOTHERAPY IN LUNG CANCER: A REAL-WORLD ORGANIZATIONAL AND ECONOMIC ASSESSMENT
Aug 11, 2026, 17:15 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CYSTIC FIBROSIS IN TURKIYE: A SCOPING REVIEW
Aug 11, 2026, 17:15 PM
